Group One Trading
BLRX

Group One Trading’s BioLineRX BLRX Stock Holding History

Group One Trading’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100
Closed -$285 – 7677
2025
Q4 		$285 Sell
100
-300
-75% -$1.04K ﹤0.01% 7857
2025
Q3 		$1.51K Sell
400
-83,700
-100% -$336K ﹤0.01% 7977
2025
Q2 		$384K Buy
+84,100
New +$311K ﹤0.01% 3687
2024
Q4 		– Sell
-230
Closed -$4.93K – 7281
2024
Q3 		$4.93K Sell
230
-8
-3% -$220 ﹤0.01% 5888
2024
Q2 		$5.38K Buy
238
+180
+310% +$4.83K ﹤0.01% 5917
2024
Q1 		$2.58K Sell
58
-1,557
-96% -$78.1K ﹤0.01% 6428
2023
Q4 		$101K Sell
1,615
-810
-33% -$50.1K ﹤0.01% 4461
2023
Q3 		$177K Buy
2,425
+1,965
+427% +$132K ﹤0.01% 3910
2023
Q2 		$29.3K Buy
+460
New +$25.5K ﹤0.01% 5696
2022
Q4 		– Sell
-600
Closed -$22K – 7250
2022
Q3 		$22K Sell
600
-108
-15% -$6.16K ﹤0.01% 5996
2022
Q2 		$36K Buy
708
+488
+222% +$27.1K ﹤0.01% 5828
2022
Q1 		$15K Buy
220
+137
+165% +$9.54K ﹤0.01% 6938
2021
Q4 		$7K Sell
83
-15
-15% -$1.56K ﹤0.01% 7502
2021
Q3 		$11K Buy
98
+30
+44% +$3.56K ﹤0.01% 7446
2021
Q2 		$8K Buy
+68
New +$7.99K ﹤0.01% 7590

Other funds holding BLRX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Group One Trading's BLRX Position: Q2 2025 in Review

Group One Trading sold out of BioLineRX (BLRX) in Q2 2025, closing a stake of 79 shares — an estimated $292 sold.

Group One Trading first reported a position in BLRX in Q3 2021 and held it in 10 quarters. The position peaked at $22K in Q4 2021. 17 funds tracked by Wall St. Rank hold BLRX as of Q2 2025.

  • Group One Trading reported no remaining BioLineRX position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 79 BioLineRX shares in Q2 2025, an estimated $292.
  • Group One Trading first reported a position in BioLineRX in Q3 2021 and held it in 10 quarters.
  • Group One Trading's BioLineRX position peaked at $22K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held BioLineRX as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.